Piedmont Healthcare
23
1
2
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
34.8%
8 terminated/withdrawn out of 23 trials
60.0%
-26.5% vs industry average
9%
2 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
Role: collaborator
RaDIANT Health Systems Intervention
Role: collaborator
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
Role: lead
AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
Role: lead
Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR
Role: lead
Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients
Role: lead
Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures
Role: collaborator
Comparative Effectiveness Research to Improve the Health of Sexual and Gender Minority Patients Through Cultural Competence and Skill Training of Community Health Center Providers and Non-clinical Staff
Role: collaborator
A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care
Role: collaborator
ULTRAsound-assisted Catheter vs. STAndaRd Catheter Thrombolysis for Submassive Pulmonary Embolism
Role: lead
In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program
Role: lead
Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU
Role: collaborator
Cardiogenomics Registry
Role: lead
Detection of Subclinical Atherosclerosis in Asymptomatic Individuals
Role: lead
Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program
Role: lead
MRI Evaluation of the Breast Areolar Margin and Paryenchyma
Role: lead
Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses
Role: lead
Atherosclerotic Plaque Characterization
Role: lead
Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)
Role: lead
Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging
Role: lead